Genor Biopharma
Biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
Market cap
$152m
Enterprise value
$13m
Share price
€0.25 67N0.F
loading funding rounds…
Hillhouse Capital(exited)
Qiming Venture Partners(exited)
Walvax Biotechnology(exited)
Conba Pharma(exited)
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (21 %) | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (3677 %) | (28843 %) | - | (4242 %) | - | 7 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (4004 %) | (29301 %) | - | (4583 %) | - | (25 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 3365 % | 6743 % | - | 3665 % | - | 98 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.